 in people with chronic kidney disease and found that there were benefits. It's being studied for liver disease, all sorts of currently off-label conditions. At Johns Hopkins, I'm Elizabeth Tracy. The VTRN Morning News. The people you know. The news you can trust. Good morning. This is Kimberly McBroom in the WDBJ 7 Newsroom with our Virginia Talk Radio Network News Update. I'm VTRN Meteorologist Matt Ferguson.